Detalles de la búsqueda
1.
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.
Int J Cancer
; 153(4): 815-825, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155342
2.
Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M.
Anticancer Drugs
; 34(10): 1146-1150, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728908
3.
Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer.
J Transl Med
; 20(1): 402, 2022 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36064706
4.
Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+-Induced Regulatory T Cells.
J Immunol
; 205(6): 1497-1502, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817370
5.
HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma.
Oncologist
; 26(9): 717-721, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896090
6.
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.
Oncologist
; 26(4): e524-e529, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997436
7.
A meta-analysis of efficacy and safety of S-1 monotherapy or combination therapy as first-line treatment in metastatic colorectal cancer.
Int J Colorectal Dis
; 35(8): 1567-1574, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32394076
8.
Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
BMC Cancer
; 18(1): 206, 2018 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463236
9.
BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.
Tumour Biol
; 35(10): 9855-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24989925
10.
New clinical trial design in precision medicine: discovery, development and direction.
Signal Transduct Target Ther
; 9(1): 57, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438349
11.
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
Front Oncol
; 13: 860711, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36910668
12.
Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden.
J Gastrointest Oncol
; 13(5): 2439-2446, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388668
13.
Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC.
Lung Cancer
; 170: 91-97, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35728482
14.
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report.
Front Oncol
; 12: 761558, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237506
15.
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial.
Eur J Cancer
; 163: 152-162, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074651
16.
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells.
Cell Oncol (Dordr)
; 45(6): 1297-1309, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260222
17.
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy.
Front Oncol
; 12: 1007146, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36686739
18.
Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer.
Front Oncol
; 11: 681946, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178671
19.
Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study.
Front Oncol
; 11: 677207, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295817
20.
Long noncoding RNA DATOC-1 that associate with DICER promotes development in epithelial ovarian cancer by upregulating miR-7 expression.
Transl Cancer Res
; 10(5): 2379-2388, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116553